| Bioactivity | Butyryltimolol, an effective prodrug of Timolol, improves the corneal penetration of Timolol[1]. Butyryltimolol is a β-adrenergic blocker[2]. | ||||||||||||
| Invitro | Butyryltimolol, a prodrug of Timolol, is equally effective as 240-min nasolacrimal blockade in enhancing ocular drug absorption[1]. | ||||||||||||
| Name | Butyryltimolol | ||||||||||||
| CAS | 106351-79-5 | ||||||||||||
| Formula | C17H30N4O4S | ||||||||||||
| Molar Mass | 386.51 | ||||||||||||
| Appearance | Liquid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Chang SC, et al. Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol. Exp Eye Res. 1988 Jan;46(1):59-69. [2]. Potter DE, et al. Ocular and cardiac beta-antagonism by timolol prodrugs, timolol and levobunolol. Curr Eye Res. 1988 Aug;7(8):755-9. |
Butyryltimolol
CAS: 106351-79-5 F: C17H30N4O4S W: 386.51
Butyryltimolol, an effective prodrug of Timolol, improves the corneal penetration of Timolol. Butyryltimolol is a β-adr
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.